Cord blood red cells for transfusion in very premature babies
Part of Blood & lymphatic, Eyes & vision, Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests whether red blood cells made from donated cord blood are safe and effective for transfusions in extremely premature infants. It aims to see if this alternative blood source can help babies born before 28 weeks or weighing less than 1000 grams.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born before 28 weeks of pregnancy or weigh less than 1000 grams at birth.
- Your baby must be in a participating NICU in the Barcelona area.
- Your baby must not have had any red blood cell transfusions before birth or after birth.
- Your baby cannot have certain conditions like severe immune reactions, fluid buildup, major birth defects, or infections passed from mother to baby.
- Your baby cannot need an immediate blood transfusion due to emergencies like bleeding or blood clotting problems.
- You must sign a consent form to allow your baby to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether red blood cell transfusions are linked to health problems in very premature babies. It may help doctors better understand how to care for these infants.
This study looks at microscopic particles called extracellular vesicles in the umbilical cord blood of babies born before 28 weeks. Researchers want to see if these particles can help predict severe health problems or death, and eventually improve care for extremely premature newborns.
This trial tests whether using a measure of oxygen in your body can guide doctors on when to give you a blood transfusion. It may help avoid unnecessary transfusions while ensuring you get enough oxygen.
This trial tests whether a type of stem cell (mesenchymal stromal cells) can help prevent bronchopulmonary dysplasia, a serious lung condition, in very premature babies. Babies born before 28 weeks who are on a breathing machine with high oxygen needs may be eligible.
This trial tests whether using specially prepared blood from umbilical cords (enriched with fetal hemoglobin) works better for premature babies who need blood transfusions. The goal is to see if this approach reduces complications and the number of transfusions needed during hospitalization.
This trial tests different ways of transferring blood from the umbilical cord to very premature babies (born at or before 32 weeks) to see if it can prevent complications of prematurity and improve their blood counts. It aims to find the best method for helping these vulnerable newborns.
Hear when a new Extremely Premature Infant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.